Health Care/Hospital

Operation Smile and Beast Philanthropy Spotlight Global Need for Access to Surgical Care

VIRGINIA BEACH, Va., Feb. 25, 2024 /PRNewswire/ -- Global nonprofit Operation Smile today announced its partnership with Beast Philanthropy, the philanthropic arm of Mr. Beast that leverages the power of social media platforms to raise funds and leave a lasting impact. Operation Smile bridges th...

2024-02-26 10:10 1254

Siriraj Hospital Expands Services to Provide Advanced Medical Care, Highlights State-of-the-Art Technology for Cancer Treatment

BANGKOK, Feb. 26, 2024 /PRNewswire/ -- Cancer continues to be one of the major health crises globally and inThailand. Siriraj Hospital, recognized as one of the largest and leading hospitals inThailand, demonstrates its readiness and dedication to delivering comprehensive medical services, includ...

2024-02-26 08:00 2030

Cure Brain Cancer Foundation CEO Lance Kawaguchi Completes SouthPoleTrek4Cancer, Raises Over $1 Million for Cancer Research

SYDNEY, Feb. 26, 2024 /PRNewswire/ -- In an unprecedented feat of endurance and dedication to cancer research,Lance Kawaguchi, Chief Executive Officer of Cure Brain Cancer Foundation, successfully completed a challenging trek at the South Pole representing more than 20 charities across six countr...

2024-02-26 06:00 1334

Zepp Health Unveils Zepp OS 3.5 with Zepp Flow™, Powered by Large Language Model AI, Pioneering the Next Generation of Wearable Intelligence Devices at MWC Barcelona 2024

MILPITAS, Calif., Feb. 26, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health") (NYSE: ZEPP), a global leader in smart wearables and health technology, today announces a significant stride in wearable intelligence with the introduction of Zepp OS 3.5, featuring Zepp Flow™. This revolution...

2024-02-26 02:00 2129

Groundbreaking! Phase II Data of LP-003 Unveiled by Longbio Pharma at AAAAI2024

WASHINGTON, Feb. 25, 2024 /PRNewswire/ -- Longbio Pharma (Suzhou) Co., Ltd. (referred to as "Longbio Pharma"), a leading biotech company dedicated to developing innovative protein treatments for allergy, respiratory, dermatology, hematology, ophthalmology, and other autoimmune and rare diseases, ...

2024-02-26 02:00 1417

China Medical University Hospital's Breakthrough: Leg Salvage Against Deadly Arterial Disease. Amputation and Death Rates Plunge from 30% to Below 3%

TAICHUNG, Feb. 24, 2024 /PRNewswire/ -- In winter, cardiovascular diseases are more prevalent, which significantly increase the likelihood of arterial blockage. In addition to increasing the possibility of accompanying myocardial infarction or stroke, seniors should be especially cautious about P...

2024-02-24 21:30 2356

China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split

HAIKOU, China, Feb. 23, 2024 /PRNewswire/ -- China Pharma Holdings Inc. ("China Pharma" or the "Company") (NYSE American: CPHI) reported that it expects to implement a 1-for-5 reverse stock split on its common stock effectiveWednesday, March 6, 2024, with trading to begin on a split-adjusted basi...

2024-02-24 05:05 4308

REP Fitness Strengthens Global Presence with Strategic Partnership in Japan

Uchinogym to Exclusively Carry the REP Line DENVER, Feb. 23, 2024 /PRNewswire/ -- Leading the charge in the fitness equipment industry, REP Fitness proudly unveils a transformative collaboration with Uchinogym, a premier distributor inJapan. This partnership signifies a significant stride in REP...

2024-02-23 23:31 3061

HeyGears Unveils Automated Case-by-Case Clear Aligner Production Solution

IRVINE, Calif., Feb. 23, 2024 /PRNewswire/ -- HeyGears , a digital manufacturing solution innovator, has announced their Automated Case-by-Case Clear Aligner Production Solution during the 39th LMT LAB DAY Chicago (LDC) event. This innovative automation-focused digital...

2024-02-23 23:00 1852

Oscotec/ADEL Initiates First-in-Human Dosing in Ph1 of Anti-MTBR Tau Antibody ADEL-Y01 In Alzheimer's Disease

PANGYO, South Korea, Feb. 23, 2024 /PRNewswire/ -- Oscotec Inc. and ADEL Inc. announced the dosing of the first healthy participant in its first-in-human study of ADEL-Y01 for the treatment of Alzheimer's disease (AD). Oscotec and ADEL are jointly developing a novel disease-modifying immunothera...

2024-02-23 21:00 1968

Pierre Fabre Laboratories, committed to combating rare pediatric diseases via innovative therapies

70% of rare genetic diseases start in childhood[1,2] CASTRES, France, Feb. 23, 2024 /PRNewswire/ -- Rare Disease Day® will be held onFebruary 29, an opportunity for Pierre Fabre Laboratories to reiterate our desire to provide innovative prescription drugs to children, as young patients require a...

2024-02-23 18:23 1771

Vantage Foundation partners with The IREDE Foundation to empower child amputees in Nigeria

LAGOS, Nigeria, Feb. 23, 2024 /PRNewswire/ -- Vantage Foundation is proud to announce its strategic partnership with The IREDE Foundation, a non-profit organisation committed to empowering children between the ages of 0 - 18 living with limb loss inNigeria to live self-sufficient lives by giving ...

2024-02-23 17:24 2245

Infinitus Awarded National Green Factory Status

The recognition marks a significant step for the health supplement producer in leading industry-wide sustainable development practices GUANGZHOU, China, Feb. 23, 2024 /PRNewswire/ -- In a recent announcement by the Ministry of Industry and Information Technology, the 2023 Green Manufacturing Li...

2024-02-23 15:40 3126

CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy

Committee for Medicinal Products for Human Use (CHMP) recommends approval of the conditional marketing authorization (CMA) for sparsentan for the treatment of IgA nephropathy (IgAN) inEurope Positive CHMP opinion is based on pivotal phase-III PROTECT study results European Commission decision is...

2024-02-23 15:00 1732

Immunofoco Announces the Dual Approval of IND Applications by the U.S. FDA and China CDE for the First EpCAM CAR-T Targeted at Advanced Solid Tumors

- The first EpCAM targeted CAR-T product obtained US/CN IND approval. - Acceptable safety profiles and preliminary efficacy were observed in Investigator-Initiated Trial (IIT) clinical studies of IMC001. SHANGHAI, Feb. 22, 2024 /PRNewswire/ -- Immunofoco, a company dedicated to developing cell ...

2024-02-23 12:51 1372

Jolly Good Revolutionizes Healthcare with Immersive Service for Apple Vision Pro, Premiering at SXSW 2024

A Milestone Entry into Spatial Computing Healthcare BROOKLINE, Mass., Feb. 22, 2024 /PRNewswire/ -- Jolly Good US Inc. proudly presents "JOLLYGOOD+ for Vision Pro," a groundbreaking immersive medical service harnessing the power of spatial computing through Apple Vision Pro technology. This inno...

2024-02-23 02:00 1713

Kakao Brain Debuts 'KARA-CXR', a Web-Based Radiology Report Service Powered by Large-Scale AI

"AI Assistant for Radiologists" * Kakao Brain introduced last month a web-based radiology report Research Use Only (RUO) service powered by its large-scale artificial intelligence (AI), "KARA-CXR." * Kakao Brain plans to expand the interactive functions supporting various imaging medical exa...

2024-02-22 21:00 2010

CATUG and Crystal Bio Establish Strategic Partnership, Launching "CATUG-Crystal" Joint Lab Dedicated to Advanced Nucleic Acid Analytical Services

CAMBRIDGE, Mass. and CRANBURY, N.J., Feb. 22, 2024 /PRNewswire/ -- CATUG Inc. (CATUG) andCrystal Bio, a member of Crystal Pharmatech, announced today a long-term strategic partnership to provide advanced nucleic acid-based drug analytical services. CATUG, a distinguished global entity specializin...

2024-02-22 21:00 1429

Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline

MELBOURNE, Australia, Feb. 22, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its results for the financial year ended31 December 2023. All figures are in AUD$ unless otherwise stated.[1] 2023 highlights * Total Group revenue of $502.5M, an...

2024-02-22 17:31 2300

Pretty Beauty Group Teams Up with Renowned Korean Medical Device Brand TENTECH to Introduce Revolutionary "TEN HI Collagen Replication Gun" Beauty Technology

HONG KONG, Feb. 22, 2024 /PRNewswire/ -- Innovative Radiofrequency Technology for Youthful, Firm Skin Pretty Beauty has recently introduced the "TEN HI Collagen Replication Gun" developed and produced by the renowned Korean medical device manufacturer TENTECH. This is an innovative and safe bea...

2024-02-22 17:12 1763
1 ... 127128129130131132133 ... 849